More patients with osteoporosis can access subsidised medication

MSD said eligibility under the PBS had expanded to patients aged 70 years or older with a BMD score of -2.5 or less and no prior fracture. The previous cut-off was -3.0 or less.

“This new criteria will provide reimbursed treatment options to a group of patients with osteoporosis who have previously had to pay on private prescription or wait for the disease to worsen,” an MSD spokesperson said. The new rules meant potentially another 200,000 people could be treated under the PBS.